iShares Biotech ETF +1.9%
Why now
Thesis: Biotech bid on rotation and rate expectations
Catalyst to watch: Clinical data or FDA decisions
Main risk: Sector rally may fade without catalysts
Why it matters
Biotech strength suggests rotation into rate-sensitive healthcare growth names.
Details
iShares Biotech ETF (IBB) moved +1.9% in the latest period (1d). Close: 211.02, prior: 207.16.
Sources
- yfinance · finance.yahoo.com · 2026-09-23 00:00 UTC